Open original FDA record ↗Recall record
- FDA identifier
- Z-2178-2017
- Company in FDA record
- AbbVie Inc.
- FDA record creation date
- May 31, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
PEG kits have the potential for one of the following defects: missing components, duplicate components or missing label/Instructions for Use, which includes expiry information.
Source facts
- Action
- On April 27, 2017, firm sent letter (and response form) to customers, instructing them to inspect their inventory for affected lots and arrange a replacement kit to be delivered by AbbVie if a kit with missing components is discovered. Distributors were asked to notify their customers. Any returned affected product will be destroyed.
- Initiated
- 2017-04-27
- Root cause
- Under Investigation by firm
- Terminated
- 2019-07-09
- Distribution
- Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, Great Britain, Greece, Croatia, Hungary, Ireland, Italy, Japan, Korea, Luxembourg, Netherlands, Norway, Portugal, Romania, Russia, Saudi Arabia, Sweden, Slovenia, Slovakia, Turkey
- Recall number
- Z-2178-2017
- Recall status
- Terminated
- CDRH record ID
- 155422
- FDA record created
- 2017-05-31
- Recall event number
- 77129